Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine’s Future
HANGZHOU, China, April 3, 2026 /PRNewswire/ -- A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, together with collaborators, published their latest findings in Nature on April 1. The study innovatively developed a pangenome-informed genome assembly (PIGA) method. By combining a cost-effective hybrid sequencing strategy of long and short reads, the team...
Syneron Bio Announces Completion of $150 Million Series B Financing
BEIJING, April 3, 2026 /PRNewswire/ -- Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31th. The round was led by an international life-science fund, with co-lead participation from Decheng Capital, and CDH VGC. Additional investors included a wholly owned subsidiary of the Abu Dhabi Investment...
VARON Marks Earth Hour 2026 with a Call for Sustainable Respiratory Care and Climate Action
NEW YORK, March 27, 2026 /PRNewswire/ -- In observance of Earth Hour 2026, VARON, a leading innovator in oxygen therapy solutions, reaffirms its commitment to advancing both respiratory health and environmental sustainability. As millions around the globe switch off their lights for one hour to raise awareness of climate change and nature loss,...
Korea’s AI-Driven Healthcare Technologies Take Centre Stage at the upcoming WHX Bangkok 2026
BANGKOK, April 3, 2026 /PRNewswire/ -- WHX Bangkok 2026 organised by Informa Markets is set to be a landmark trade event for showcasing Korea's groundbreaking advancements in AI-driven healthcare and technology. Two leading Korean companies, Korea Body Information Co., Ltd. and maihub, will unveil their flagship solutions at the trade show taking place from 8 – 10 July 2026 at...
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX's industry-leading global network of electronic health record data Collaboration will expand Regeneron's world-leading genomic and proteomic EHR-linked database Growing database will continue to drive drug discovery and development and empower AI training algorithms to deliver digital...
Education Cannot Wait Launches Urgent Support to Protect Learning for Crisis-Affected Children in Lebanon
On her first day as ECW Director, Maysa Jalbout visits Lebanon to reaffirm ECW's commitment to the country's children, announce new emergency funding and mobilise urgent international support. BEIRUT, April 2, 2026 /PRNewswire/ -- Education Cannot Wait (ECW) today reaffirmed their strong partnership with Lebanon's Ministry of Education and Higher Education (MEHE) to...
ZEISS advances connected cataract and refractive workflows with new digital, AI and surgical innovations at ASCRS
ZEISS Medical Technology will discuss and showcase latest workflow technologies at ASCRS 2026: Enhanced Cataract Workflow Efficiency and Patient Outcomes: MicroSurgical Technology irrigation/aspiration handpieces, tips and sleeves, now available for the DORC EVA NEXUS to offer increased surgical sustainability and incision options; ZEISS IOLMaster 700 and ZEISS VERACITY Surgery Planner offer...
Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
WILMINGTON, Del., April 2, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase IIa clinical trial of HXN-1001, a half-life extended anti-TL1A antibody, in patients with ulcerative colitis, as well as enrollment completion in the Phase I trial of the antibody in healthy volunteers carried out...
Lupin Completes Acquisition of VISUfarma
MUMBAI, India and LONDON and ROME and ZUG, Switzerland, April 2, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP...
StairMed Secures RMB 500 Million Financing Led by Alibaba, Joined by Tencent
SHANGHAI, April 2, 2026 /PRNewswire/ -- Shanghai StairMed Technology Co., Ltd. ("StairMed" or "the Company") recently announced the closing of a strategic financing round totaling RMB 500 million. The round was led by Alibaba, with strong continued participation from existing shareholders including Tencent, Fountainbridge Capital, OrbiMed, Oriza Seed, Qiming Venture Partners, Lilly Asia Ventures (LAV), and Source Code Capital, etc....
